European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another hurdle for the companies as they scramble to boost uptake of the therapy in the U.S. The European Commission, the EU’s executive body, has a final say in Leqembi’s approval. But it almost always follows the drug regulator’s recommendations. … Read more
Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped 16% in premarket trading Thursday after the biotech company a day earlier announced plans to advance its experimental weight loss injection into a late-stage trial earlier than expected. It brings the San Diego-based company one step closer to joining the … Read more
Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City. Michael M. Santiago | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no … Read more
Novo Nordisk and Eli Lilly shares slid Wednesday after Roche announced promising early-stage trial data from its latest obesity drug candidate. The Swiss pharmaceutical giant said Wednesday that a second drug candidate from its purchase of Carmot Therapeutics indicated positive results, further heating up competition in the weight loss drug market. Roche shares jumped in … Read more
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Novo Nordisk‘s blockbuster diabetes drug Ozempic may have more to offer beyond … Read more
Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Several drugmakers are hurrying to capitalize on one of the next major innovations coming to the booming weight loss drug market: effective, convenient and potentially affordable obesity pills. Most of the … Read more
My top 10 things to watch Thursday, July 11 The S & P 500 and Nasdaq , both on seven-session winning streaks, were looking lower after more records. The June consumer price index year over year came in around its lowest inflation level in more than three years. Stock futures were initially higher on the … Read more
Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it saw “encouraging” data in an ongoing early-stage trial. The company evaluated several once-daily formulations of the drug and identified one with “the most favorable profile.” Pfizer said it … Read more
CNBC’s Jim Cramer on Wednesday gave his take on Hims & Hers Health, a digital platform that offers telehealth services, particularly for sexual health, mental health, weight loss and skin care. Hims & Hers also provides direct-to-consumer treatments for conditions like erectile dysfunction and hair loss. Cramer suggested it might be worth starting a position … Read more
FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled “Fiscal Year 2025 Request for the Federal Trade Commission,” in Rayburn Building on Wednesday, May 15, 2024. Tom Williams | CQ-Roll Call, Inc. | Getty Images The Federal Trade Commission is planning to sue three large U.S. … Read more
